RWM
NMTC icon

Revisor Wealth Management’s NeuroOne Medical Technologies NMTC Stock Holding History

Revisor Wealth Management’s Portfolio NMTC Stock Details NMTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,263
Closed -$15.2K – 381
2026
Q1 		$15.2K Buy
+3,263
New +$15.7K ﹤0.01% 324

Other funds holding NMTC

BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Revisor Wealth Management's NMTC Position: Q2 2026 in Review

Revisor Wealth Management sold out of NeuroOne Medical Technologies (NMTC) in Q2 2026, closing a stake of 3,263 shares — an estimated $15.2K sold.

Revisor Wealth Management first reported a position in NMTC in Q1 2026 and held it in 1 quarter. The position peaked at $15.2K in Q1 2026. 27 funds tracked by Wall St. Rank hold NMTC as of Q2 2026.

  • Revisor Wealth Management reported no remaining NeuroOne Medical Technologies position as of Q2 2026 after selling out during the quarter.
  • Revisor Wealth Management sold 3,263 NeuroOne Medical Technologies shares in Q2 2026, an estimated $15.2K.
  • Revisor Wealth Management first reported a position in NeuroOne Medical Technologies in Q1 2026 and held it in 1 quarter.
  • Revisor Wealth Management's NeuroOne Medical Technologies position peaked at $15.2K in Q1 2026.
  • 27 funds tracked by Wall St. Rank held NeuroOne Medical Technologies as of Q2 2026.

Based on Revisor Wealth Management's 13F filing for Q2 2026, filed 22 Jul 2026.